MedPath

ENPRESSE

ENPRESSE™ – 28 TABLETS(levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)

Approved
Approval ID

a3db80f8-5026-4954-aef5-dbf14c8c1b16

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-4860
Application NumberANDA075809
Product Classification
M
Marketing Category
C73584
G
Generic Name
levonorgestrel and ethinyl estradiol
Product Specifications
Effective DateMarch 16, 2011
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENPRESSE - FDA Drug Approval Details